These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11297616)

  • 1. Angiogenesis inhibition in the in vivo antineoplastic effect of manumycin and paclitaxel against anaplastic thyroid carcinoma.
    Xu G; Pan J; Martin C; Yeung SC
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1769-77. PubMed ID: 11297616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manumycin enhances the cytotoxic effect of paclitaxel on anaplastic thyroid carcinoma cells.
    Yeung SC; Xu G; Pan J; Christgen M; Bamiagis A
    Cancer Res; 2000 Feb; 60(3):650-6. PubMed ID: 10676649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy including combretastatin A4 phosphate and paclitaxel is effective against anaplastic thyroid cancer in a nude mouse xenograft model.
    Yeung SC; She M; Yang H; Pan J; Sun L; Chaplin D
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2902-9. PubMed ID: 17550961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining a matrix metalloproteinase inhibitor, a farnesyltransferase inhibitor, and a taxane improves survival in an anaplastic thyroid cancer model.
    She M; Jim Yeung SC
    Cancer Lett; 2006 Jul; 238(2):197-201. PubMed ID: 16154259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antitumor and anti-angiogenic effects of manumycin on human hepatocellular carcinoma HepG2 xenografts in nude mice].
    Zhou JM; Zhu XF; Liu ZC; Fu LW; Yang XP; Liang YJ; Pan QC
    Ai Zheng; 2005 Aug; 24(8):935-9. PubMed ID: 16086869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2-associated X protein is the main mediator of manumycin a-induced apoptosis in anaplastic thyroid cancer cells.
    Pan J; Huang H; Sun L; Fang B; Yeung SC
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3583-91. PubMed ID: 15769983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p21 Waf-1 (Cip-1) enhances apoptosis induced by manumycin and paclitaxel in anaplastic thyroid cancer cells.
    Yang HL; Pan JX; Sun L; Yeung SC
    J Clin Endocrinol Metab; 2003 Feb; 88(2):763-72. PubMed ID: 12574211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome c release is upstream to activation of caspase-9, caspase-8, and caspase-3 in the enhanced apoptosis of anaplastic thyroid cancer cells induced by manumycin and paclitaxel.
    Pan J; Xu G; Yeung SC
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4731-40. PubMed ID: 11600533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma.
    Inoue K; Slaton JW; Perrotte P; Davis DW; Bruns CJ; Hicklin DJ; McConkey DJ; Sweeney P; Radinsky R; Dinney CP
    Clin Cancer Res; 2000 Dec; 6(12):4874-84. PubMed ID: 11156247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aplidin reduces growth of anaplastic thyroid cancer xenografts and the expression of several angiogenic genes.
    Straight AM; Oakley K; Moores R; Bauer AJ; Patel A; Tuttle RM; Jimeno J; Francis GL
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):7-14. PubMed ID: 16001179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of parathyroid hormone-related protein levels (PTHrP) in anaplastic thyroid cancer.
    Dackiw A; Pan J; Xu G; Yeung SC
    Surgery; 2005 Sep; 138(3):456-63. PubMed ID: 16213899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor monoclonal antibody inhibits growth of anaplastic thyroid cancer xenografts in nude mice.
    Bauer AJ; Terrell R; Doniparthi NK; Patel A; Tuttle RM; Saji M; Ringel MD; Francis GL
    Thyroid; 2002 Nov; 12(11):953-61. PubMed ID: 12490072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted molecular therapy of anaplastic thyroid carcinoma with AEE788.
    Kim S; Schiff BA; Yigitbasi OG; Doan D; Jasser SA; Bekele BN; Mandal M; Myers JN
    Mol Cancer Ther; 2005 Apr; 4(4):632-40. PubMed ID: 15827337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combretastatin A4 phosphate has primary antineoplastic activity against human anaplastic thyroid carcinoma cell lines and xenograft tumors.
    Dziba JM; Marcinek R; Venkataraman G; Robinson JA; Ain KB
    Thyroid; 2002 Dec; 12(12):1063-70. PubMed ID: 12593719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors.
    Sweeney CJ; Miller KD; Sissons SE; Nozaki S; Heilman DK; Shen J; Sledge GW
    Cancer Res; 2001 Apr; 61(8):3369-72. PubMed ID: 11309294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis.
    Naumova E; Ubezio P; Garofalo A; Borsotti P; Cassis L; Riccardi E; Scanziani E; Eccles SA; Bani MR; Giavazzi R
    Clin Cancer Res; 2006 Mar; 12(6):1839-49. PubMed ID: 16551869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.
    Ciardiello F; Caputo R; Bianco R; Damiano V; Fontanini G; Cuccato S; De Placido S; Bianco AR; Tortora G
    Clin Cancer Res; 2001 May; 7(5):1459-65. PubMed ID: 11350918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tyrosine kinase inhibitor, AZD2171, inhibits vascular endothelial growth factor receptor signaling and growth of anaplastic thyroid cancer in an orthotopic nude mouse model.
    Gomez-Rivera F; Santillan-Gomez AA; Younes MN; Kim S; Fooshee D; Zhao M; Jasser SA; Myers JN
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4519-27. PubMed ID: 17671138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
    Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
    Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.